AXB

70.1

0%↓

BRKB

510.42

-0.66%↓

BRKA.US

765,290

-0.66%↓

JPM

267.36

-0.01%↓

V

367.46

+0.65%↑

AXB

70.1

0%↓

BRKB

510.42

-0.66%↓

BRKA.US

765,290

-0.66%↓

JPM

267.36

-0.01%↓

V

367.46

+0.65%↑

AXB

70.1

0%↓

BRKB

510.42

-0.66%↓

BRKA.US

765,290

-0.66%↓

JPM

267.36

-0.01%↓

V

367.46

+0.65%↑

AXB

70.1

0%↓

BRKB

510.42

-0.66%↓

BRKA.US

765,290

-0.66%↓

JPM

267.36

-0.01%↓

V

367.46

+0.65%↑

AXB

70.1

0%↓

BRKB

510.42

-0.66%↓

BRKA.US

765,290

-0.66%↓

JPM

267.36

-0.01%↓

V

367.46

+0.65%↑

Search

KKR & Co LP

Gesloten

SectorFinanciën

125.83 0.2

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

125.75

Max

126.12

Belangrijke statistieken

By Trading Economics

Inkomsten

-700M

684M

Verkoop

-90M

3.1B

K/W

Sectorgemiddelde

38.177

24.598

EPS

1.15

Dividendrendement

0.59

Winstmarge

22.008

Werknemers

4,834

EBITDA

-17M

1.5B

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+13.25% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

0.59%

4.30%

Volgende Winsten

30 jul 2025

Volgende dividenddatum

27 mei 2025

Volgende Ex Dividend datum

11 aug 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

9.9B

116B

Vorige openingsprijs

125.63

Vorige sluitingsprijs

125.83

Nieuwssentiment

By Acuity

21%

79%

43 / 540 Rangschikking in Finance

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

KKR & Co LP Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

1 mei 2025, 14:11 UTC

Winsten

KKR Swings to 1Q Loss, Asset Management Sales Rise

30 apr 2025, 14:14 UTC

Acquisities, Fusies, Overnames

GlobalData Gets Takeover Approaches From KKR, ICG Europe Fund

22 apr 2025, 06:50 UTC

Acquisities, Fusies, Overnames

KKR Launches $1.2 Billion Takeover Bid For Swedish Life-Sciences Company Biotage

14 apr 2025, 11:46 UTC

Acquisities, Fusies, Overnames

CME Group, S&P Group Agree to Sell OSTTRA to KKR in $3.1 Billion Deal

9 apr 2025, 10:24 UTC

Acquisities, Fusies, Overnames

EQT to Sell Karo Healthcare to KKR

16 mei 2025, 20:11 UTC

Acquisities, Fusies, Overnames

Henry Schein: William K. Daniel Joins Board

16 mei 2025, 20:10 UTC

Acquisities, Fusies, Overnames

Henry Schein: Strategic Investment by KKR Completed

16 mei 2025, 09:30 UTC

Top Nieuws

Wall Street's New 'Shadow Banks' Are on a Tear. They Want Your Money. -- WSJ

1 mei 2025, 10:55 UTC

Winsten

KKR Declares Qtrly Div of 18.5/Share >KKR

1 mei 2025, 10:54 UTC

Winsten

KKR 1Q Rev $3.11B >KKR

1 mei 2025, 10:54 UTC

Winsten

KKR 1Q Insurance Revenue $1.06B >KKR

1 mei 2025, 10:54 UTC

Winsten

KKR 1Q Asset-Management and Strategic Holdings Revenue $2.05B >KKR

1 mei 2025, 10:54 UTC

Winsten

KKR 1Q-End Assets Under Management $664B >KKR

1 mei 2025, 10:54 UTC

Winsten

KKR 1Q Fee-Related Earnings $823M, or 92c/Adj. Share >KKR

1 mei 2025, 10:53 UTC

Winsten

KKR 1Q Loss/Shr 22c >KKR

22 apr 2025, 06:04 UTC

Acquisities, Fusies, Overnames

KKR: Offer Price Represents 60% Premium to Thursday's Closing Price

22 apr 2025, 06:03 UTC

Acquisities, Fusies, Overnames

KKR: Biotage Board Recommends Shareholders Accept Offer

22 apr 2025, 06:02 UTC

Acquisities, Fusies, Overnames

KKR: Offer Values Biotage at SEK11.61B

22 apr 2025, 06:02 UTC

Acquisities, Fusies, Overnames

KKR Makes SEK145 a Share Bid For Biotage

18 apr 2025, 00:00 UTC

Top Nieuws

Private Equity World Engulfed by Perfect Storm -- WSJ

14 apr 2025, 11:31 UTC

Top Nieuws
Acquisities, Fusies, Overnames

CME Group, S&P Group Agree to Sell OSTTRA to KKR in $3.1B Deal

14 apr 2025, 11:02 UTC

Acquisities, Fusies, Overnames

KKR: Making OSTTRA Investment Primarily Through North America Private-Equity Strategy >KKR

14 apr 2025, 11:01 UTC

Acquisities, Fusies, Overnames

S&P Global, CME to Divide Sale Proceeds Evenly Pursuant to 50/50 Joint Venture >SPGI CME

14 apr 2025, 11:00 UTC

Acquisities, Fusies, Overnames

S&P Global, CME Group to Sell OSTTRA to KKR for $3.1 Billion >SPGI CME KKR

14 apr 2025, 11:00 UTC

Acquisities, Fusies, Overnames

S&P Global and CME Group to Sell OSTTRA to KKR for $3.1 Billion

11 apr 2025, 11:56 UTC

Acquisities, Fusies, Overnames

KKR Now Owns 30% of Enilive

11 apr 2025, 11:55 UTC

Acquisities, Fusies, Overnames

KKR Completes Acquisition of Additional Stake in Enilive

9 apr 2025, 09:51 UTC

Acquisities, Fusies, Overnames

EQT to Sell Karo Healthcare to KKR for an Undisclosed Amount

9 apr 2025, 09:32 UTC

Acquisities, Fusies, Overnames

EQT: Transaction Expected to Close in Coming Months

9 apr 2025, 09:31 UTC

Acquisities, Fusies, Overnames

EQT to Sell Karo Healthcare to KKR

Peer Vergelijking

Prijswijziging

KKR & Co LP Prognose

Koersdoel

By TipRanks

13.25% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 142.58 USD  13.25%

Hoogste 194 USD

Laagste 119 USD

Gebaseerd op 12 Wall Street-analisten die 12-maands prijsdoelen bieden voor KKR & Co LP - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

12 ratings

12

Buy

0

Hold

0

Sell

Technische score

By Trading Central

114.51 / N/ASteun & Weerstand

Korte Termijn

Bullish Evidence

Gemiddeld Termijn

Neutral Evidence

Lange Termijn

Weak Bearish Evidence

Sentiment

By Acuity

43 / 540 Rangschikking in Financiën

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over KKR & Co LP

KKR & Co. Inc. is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market, and middle market investments. The firm considers investments in all industries with a focus on software, security, semiconductors, consumer electronics, internet of things (iot), internet, information services, information technology infrastructure, financial technology, network and cyber security architecture, engineering and operations, content, technology and hardware, energy and infrastructure, real estate, services industry with a focus on business services, intelligence, industry-leading franchises and companies in natural resource, containers and packaging, agriculture, airports, ports, forestry, electric utilities, textiles, apparel and luxury goods, household durables, digital media, insurance, brokerage houses, non-durable goods distribution, supermarket retailing, grocery stores, food, beverage, and tobacco, hospitals, entertainment venues and production companies, publishing, printing services, capital goods, financial services, specialized finance, pipelines, and renewable energy. In energy and infrastructure, it focuses on the upstream oil and gas and equipment, minerals and royalties and services verticals. In real estate, the firm seeks to invest in private and public real estate securities including property-level equity, debt and special situations transactions and businesses with significant real estate holdings, and oil and natural gas properties. The firm also invests in asset services sector that encompasses a broad array of B2B, B2C and B2G services verticals including asset-based, transport, logistics, leisure/hospitality, resource and utility support, infra-like, mission-critical, and environmental services. Within Americas, the firm prefers to invest in consumer products; chemicals, metals and m